Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Looking for the best credit card with point redemption options? Explore top choices that help you maximize your rewards effectively.
28,317 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Bank of America initiates coverage on Salesforce with an Underperform rating and a $160 price target, highlighting un...
The Gedalje Group climbs to the top 10 in RealTrends' 2026 The Thousand rankings after closing 468 sides and $245 mil...
As Brazil begins a measured rate-cut cycle, EWZ may emerge as a tactical edge in 2026. A slower Fed and a stronger BR...
A hypothetical move where Paramount aligns with Warner Bros. Discovery would ripple through streaming, financing, and...
Wall Street and crypto traders watch a quiet moment for Bitcoin as geopolitical tensions cool and ETF inflows grow. T...
Pinterest sparked a noticeable stock move after its Q1 results, but a single quarter rarely writes the full comeback ...
A wave of AI-related investment, pegged at $750 billion, is reshaping expectations for NVIDIA, Alphabet, and Oracle a...
Salesforce faces a growth hurdle in a fast-moving AI world. This article explains how a targeted acquisition could fi...
As crypto ETFs mature in 2026, XRP spot products and HYPE ETFs clash for traders. This article compares assets, liqui...
The AI boom is reshaping the tech stock landscape, putting Nvidia and Micron in the spotlight. This guide teases out ...
With crude hovering near $70, some investors wonder if energy stocks can keep delivering. This article explains why t...